The estimated Net Worth of Michael Finegan is at least $5.63 Million dollars as of 5 June 2020. Michael Finegan owns over 8,750 units of Orthofix Medical Inc stock worth over $986,284 and over the last 17 years Michael sold OFIX stock worth over $4,646,074.
Michael has made over 13 trades of the Orthofix Medical Inc stock since 2012, according to the Form 4 filled with the SEC. Most recently Michael exercised 8,750 units of OFIX stock worth $190,575 on 5 June 2020.
The largest trade Michael's ever made was selling 80,972 units of Orthofix Medical Inc stock on 14 April 2016 worth over $3,458,314. On average, Michael trades about 5,848 units every 72 days since 2007. As of 5 June 2020 Michael still owns at least 56,683 units of Orthofix Medical Inc stock.
You can see the complete history of Michael Finegan stock trades at the bottom of the page.
Michael's mailing address filed with the SEC is 3451 PLANO PARKWAY, , LEWISVILLE, TX, 75056.
Over the last 22 years, insiders at Orthofix Medical Inc have traded over $19,062,472 worth of Orthofix Medical Inc stock and bought 182,076 units worth $5,806,101 . The most active insiders traders include Stuart Essig, Charles R. Kummeth und Alexis V Lukianov. On average, Orthofix Medical Inc executives and independent directors trade stock every 53 days with the average trade being worth of $179,237. The most recent stock trade was executed by Kevin J. Kenny on 8 January 2024, trading 5,959 units of OFIX stock currently worth $103,687.
orthofix international began in a small farmhouse in verona italy in 1980 when orthopedic researcher giovanni de bastiani recognized the bone’s natural repair capability, a concept he called “dynamization” and with that in mind, he created the first external fixation device. today, orthofix has grown to more than 900 employees with locations in the u.s., italy, germany, france, the uk, brazil, australia and puerto rico. our products help patients in 70 countries around the world. the company is comprised of four strategic business units; biostim, biologics, extremity fixation and spine fixation. our products are widely distributed via the company's sales representatives, distributors and subsidiaries. at orthofix we are committed to clinical research and driven by new product introductions. we are proud of our strong partnerships with organizations such as the texas scottish rite hospital for children in dallas and the musculoskeletal transplant foundation. we take pride in developing
Orthofix Medical Inc executives and other stock owners filed with the SEC include: